SCHEMBL30684197

SCHEMBL30684197

CCOc1cc(Cl)c(Cl)c2c1c(-c1cnn(C3CCCCO3)c1)c1n2CC[C@H]1NC(C)=O

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM5B Q9UGL1 1/20 0.33
▸ FGFR1 P11362 3/20 0.33
▸ P2RY12 Q9H244 1/20 0.32
▸ FLT3 P36888 2/20 0.32
▸ FGFR2 P21802 1/20 0.32
▸ FGFR4 P22455 1/20 0.32
▸ FGFR3 P22607 1/20 0.32
▸ KDR P35968 1/20 0.32
▸ SYK P43405 1/20 0.31
▸ AURKB Q96GD4 1/20 0.31
▸ MCL1 Q07820 1/20 0.31
▸ ACACB O00763 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ ATR Q13535 1/20 0.30
▸ DDR2 Q16832 1/20 0.30
▸ RXRA P19793 1/20 0.30
▸ RXRB P28702 1/20 0.30
▸ RXRG P48443 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26913324 1.00 KDM5B (0.33) KDM5BFGFR1P2RY12FLT3FGFR2
SCHEMBL26912583 1.00 KDM5B (0.33) KDM5BFGFR1P2RY12FLT3FGFR2
SCHEMBL30684321 1.00 KDM5B (0.33) KDM5BFGFR1P2RY12FLT3FGFR2
SCHEMBL30684306 0.92 KDM5B (0.32) KDM5BFGFR1FLT3FGFR2FGFR4
SCHEMBL26912865 0.92 KDM5B (0.32) KDM5BFGFR1FLT3FGFR2FGFR4
SCHEMBL30684276 0.92 KDM5B (0.32) KDM5BFGFR1FLT3FGFR2FGFR4
SCHEMBL26912365 0.92 KDM5B (0.32) KDM5BFGFR1FLT3FGFR2FGFR4
SCHEMBL26912631 0.88 KDM5B (0.33) KDM5BFGFR1FLT3FGFR2FGFR4
SCHEMBL30684418 0.85 KDM5B (0.31) KDM5BFGFR1
SCHEMBL26913756 0.85 KDM5B (0.31) KDM5BFGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023235809-A1 CGAS INHIBITORS ELI LILLY AND COMPANY (US) 2023-12-07 — — WO disclosed
Send feedback